on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. has submitted Form 8.3 to the Irish Takeover Panel, disclosing its stake in Mural Oncology plc. As of July 9, 2025, Vanguard holds 772,739 ordinary shares at $0.01 each, representing a 4.47% interest in Mural Oncology.
The disclosure indicates no other positions, such as cash-settled or stock-settled derivatives. The form confirms no other parties connected to this offer and no agreements affecting voting rights or future acquisitions were mentioned.
Additionally, Vanguard reported a recent transaction involving the sale of 48 ordinary shares of Mural Oncology at a unit price of 2.56 USD. No indemnity or option arrangements have been established in connection to Mural Oncology's securities.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news